Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated?

World J Gastroenterol. 2011 Dec 14;17(46):5083-8. doi: 10.3748/wjg.v17.i46.5083.

Abstract

Aim: To analyze the outcome of hepatocellular carcinoma (HCC) resection in cirrhosis patients, related to presence of portal hypertension (PH) and extent of hepatectomy.

Methods: A retrospective analysis of 135 patients with HCC on a background of cirrhosis was submitted to curative liver resection.

Results: PH was present in 44 (32.5%) patients. Overall mortality and morbidity were 2.2% and 33.7%, respectively. Median survival time in patients with or without PH was 31.6 and 65.1 mo, respectively (P = 0.047); in the subgroup with Child-Pugh class A cirrhosis, median survival was 65.1 mo and 60.5 mo, respectively (P = 0.257). Survival for patients submitted to limited liver resection was not significantly different in presence or absence of PH. Conversely, median survival for patients after resection of 2 or more segments with or without PH was 64.4 mo and 163.9 mo, respectively (P = 0.035).

Conclusion: PH is not an absolute contraindication to liver resection in Child-Pugh class A cirrhotic patients, but resection of 2 or more segments should not be recommended in patients with PH.

Keywords: Hepatic resection; Hepatocellular carcinoma; Liver surgery; Portal hypertension.

MeSH terms

  • Aged
  • Carcinoma, Hepatocellular / etiology
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / surgery*
  • Contraindications
  • Female
  • Hepatectomy* / mortality
  • Humans
  • Hypertension, Portal / physiopathology*
  • Hypertension, Portal / surgery
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / pathology
  • Liver Cirrhosis / surgery*
  • Liver Neoplasms / etiology
  • Liver Neoplasms / mortality
  • Liver Neoplasms / pathology
  • Liver Neoplasms / surgery*
  • Male
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome